|
Symbol Name ID |
Slc6a14
solute carrier family 6 (neurotransmitter transporter), member 14 MGI:1890216 |
| Allelic Composition Genetic Background |
Annotated Term | Reference |
| Slc6a14tm1Gana/Slc6a14tm1Gana Tg(MMTV-PyVT)634Mul/0 Not Specified |
abnormal amino acid level | J:226105 |
| abnormal immunoglobulin level | J:226105 | |
| decreased metastatic potential | J:226105 | |
| decreased tumor growth/size | J:226105 | |
| increased tumor latency | J:226105 | |
| Slc6a14tm1Gana/Slc6a14tm1Gana Tg(MMTVneu)202Mul/0 involves: FVB/N |
decreased mammary gland tumor incidence | J:226105 |
| decreased tumor growth/size | J:226105 | |
| increased tumor latency | J:226105 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 10/07/2025 MGI 6.24 |
|
|
|
||